Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 26, 2021 at 05:07 am EDT
Qianjiang Yongan Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 1,125.36 million compared to CNY 891.4 million a year ago. Revenue was CNY 1,125.36 million compared to CNY 891.4 million a year ago. Net income was CNY 82.41 million compared to CNY 114.64 million a year ago. Basic earnings per share from continuing operations was CNY 0.29 compared to CNY 0.4 a year ago. Diluted earnings per share from continuing operations was CNY 0.29 compared to CNY 0.4 a year ago.